FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2737085818> ?p ?o ?g. }

• W2737085818 endingPage "65931" @default.
• W2737085818 startingPage "65917" @default.
• W2737085818 abstract "// Dmitry Pankov 1, * , Ludvig Sjöström 3, 4, * , Teja Kalidindi 5 , Sang-Gyu Lee 5 , Kjell Sjöström 9 , Rui Gardner 2 , Michael R. McDevitt 5, 10 , Richard O’Reilly 1, 8, 10 , Daniel L.J. Thorek 7, 11 , Steven M. Larson 5, 6 , Darren Veach 5, 6 and David Ulmert 3, 4 1 Immunology Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA 2 Flow Cytometry Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA 3 Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 4 Division of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden 5 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 6 Department of Radiology, Weill Cornell Medical College, New York, NY, USA 7 Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA 8 Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA 9 Innovagen AB, Lund, Sweden 10 Department of Medicine, Weill Cornell Medical College, New York, NY, USA 11 Cancer Molecular and Functional Imaging Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA * These authors have contributed equally to this work Correspondence to: David Ulmert, email: ulmerth@mskcc.org Keywords: PRAME, immuno-targeting, cancer, noninvasive imaging, targeted therapy Received: April 13, 2017     Accepted: June 26, 2017     Published: July 26, 2017 ABSTRACT Preferentially Expressed Antigen in Melanoma (PRAME) is a cancer/testis antigen that is overexpressed in a broad range of malignancies, while absent in most healthy human tissues, making it an attractive diagnostic cancer biomarker and therapeutic target. Although commonly viewed as an intracellular protein, we have demonstrated that PRAME has a membrane bound form with an external epitope targetable with conventional antibodies. We generated a polyclonal antibody (Membrane associated PRAME Antibody 1, MPA1) against an extracellular peptide sequence of PRAME. Binding of MPA1 to recombinant PRAME was evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Flow cytometry and confocal immunofluorescence microscopy of MPA1 was performed on multiple tumor cell lines. Reverse Transcription Polymerase Chain Reaction (RT-PCR) for PRAME was conducted to compare protein and transcriptional expression levels. We demonstrated a robust proof-of-concept for PRAME targeting in vivo by radiolabeling MPA1 with zirconium-89 ( 89 Zr-DFO-MPA1) and demonstrating high specific uptake in PRAME expressing tumors. To our knowledge, this is the first time a cancer testis antigen has been targeted using conventional antibody technologies. Thus, PRAME can be exploited for multiple clinical applications, including targeted therapy, diagnostic imaging and treatment guidance in a wide-range of malignancies, with minimal off-target toxicity." @default.
• W2737085818 created "2017-07-31" @default.
• W2737085818 creator A5015396908 @default.
• W2737085818 creator A5028818771 @default.
• W2737085818 creator A5032224234 @default.
• W2737085818 creator A5058476408 @default.
• W2737085818 creator A5063978721 @default.
• W2737085818 creator A5067808348 @default.
• W2737085818 creator A5068912186 @default.
• W2737085818 creator A5072467081 @default.
• W2737085818 creator A5075150288 @default.
• W2737085818 creator A5075653007 @default.
• W2737085818 creator A5081366346 @default.
• W2737085818 creator A5086109194 @default.
• W2737085818 date "2017-07-26" @default.
• W2737085818 modified "2023-10-01" @default.
• W2737085818 title "<i>In vivo</i> immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)" @default.
• W2737085818 cites W1510345640 @default.
• W2737085818 cites W1967838516 @default.
• W2737085818 cites W1968948384 @default.
• W2737085818 cites W1975909563 @default.
• W2737085818 cites W1976515482 @default.
• W2737085818 cites W1978164044 @default.
• W2737085818 cites W1988065916 @default.
• W2737085818 cites W1990261637 @default.
• W2737085818 cites W1993191461 @default.
• W2737085818 cites W1994328316 @default.
• W2737085818 cites W2017307891 @default.
• W2737085818 cites W2030275902 @default.
• W2737085818 cites W2045522616 @default.
• W2737085818 cites W2056534555 @default.
• W2737085818 cites W2056707829 @default.
• W2737085818 cites W2066311819 @default.
• W2737085818 cites W2075632851 @default.
• W2737085818 cites W2109623522 @default.
• W2737085818 cites W2112470258 @default.
• W2737085818 cites W2125685908 @default.
• W2737085818 cites W2147157147 @default.
• W2737085818 cites W2153264881 @default.
• W2737085818 cites W2170596459 @default.
• W2737085818 cites W2518946049 @default.
• W2737085818 cites W2520587924 @default.
• W2737085818 doi "https://doi.org/10.18632/oncotarget.19579" @default.
• W2737085818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5630382" @default.
• W2737085818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29029482" @default.
• W2737085818 hasPublicationYear "2017" @default.
• W2737085818 type Work @default.
• W2737085818 sameAs 2737085818 @default.
• W2737085818 citedByCount "15" @default.
• W2737085818 countsByYear W27370858182019 @default.
• W2737085818 countsByYear W27370858182020 @default.
• W2737085818 countsByYear W27370858182021 @default.
• W2737085818 countsByYear W27370858182022 @default.
• W2737085818 countsByYear W27370858182023 @default.
• W2737085818 crossrefType "journal-article" @default.
• W2737085818 hasAuthorship W2737085818A5015396908 @default.
• W2737085818 hasAuthorship W2737085818A5028818771 @default.
• W2737085818 hasAuthorship W2737085818A5032224234 @default.
• W2737085818 hasAuthorship W2737085818A5058476408 @default.
• W2737085818 hasAuthorship W2737085818A5063978721 @default.
• W2737085818 hasAuthorship W2737085818A5067808348 @default.
• W2737085818 hasAuthorship W2737085818A5068912186 @default.
• W2737085818 hasAuthorship W2737085818A5072467081 @default.
• W2737085818 hasAuthorship W2737085818A5075150288 @default.
• W2737085818 hasAuthorship W2737085818A5075653007 @default.
• W2737085818 hasAuthorship W2737085818A5081366346 @default.
• W2737085818 hasAuthorship W2737085818A5086109194 @default.
• W2737085818 hasBestOaLocation W27370858181 @default.
• W2737085818 hasConcept C121608353 @default.
• W2737085818 hasConcept C126322002 @default.
• W2737085818 hasConcept C143998085 @default.
• W2737085818 hasConcept C71924100 @default.
• W2737085818 hasConceptScore W2737085818C121608353 @default.
• W2737085818 hasConceptScore W2737085818C126322002 @default.
• W2737085818 hasConceptScore W2737085818C143998085 @default.
• W2737085818 hasConceptScore W2737085818C71924100 @default.
• W2737085818 hasIssue "39" @default.
• W2737085818 hasLocation W27370858181 @default.
• W2737085818 hasLocation W27370858182 @default.
• W2737085818 hasLocation W27370858183 @default.
• W2737085818 hasLocation W27370858184 @default.
• W2737085818 hasOpenAccess W2737085818 @default.
• W2737085818 hasPrimaryLocation W27370858181 @default.
• W2737085818 hasRelatedWork W1506200166 @default.
• W2737085818 hasRelatedWork W1995515455 @default.
• W2737085818 hasRelatedWork W2080531066 @default.
• W2737085818 hasRelatedWork W2224319365 @default.
• W2737085818 hasRelatedWork W2748952813 @default.
• W2737085818 hasRelatedWork W2899084033 @default.
• W2737085818 hasRelatedWork W2989971117 @default.
• W2737085818 hasRelatedWork W3031052312 @default.
• W2737085818 hasRelatedWork W3032375762 @default.
• W2737085818 hasRelatedWork W3108674512 @default.
• W2737085818 hasVolume "8" @default.
• W2737085818 isParatext "false" @default.
• W2737085818 isRetracted "false" @default.
• W2737085818 magId "2737085818" @default.
• W2737085818 workType "article" @default.